Condition
Peripheral T-cell Lymphoma (PTCL) clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Peripheral T-cell Lymphoma (PTCL) clinical trials that are recruiting, at sites in 11 countries (most in China (2), Australia (1), Brazil (1)). By phase: Phase 1/2 (1), Early Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 11Countries
All recruiting trials (2)
-
Anti-EBV autologous TCR-T cell injection for relapsed or refractory EBV-positive lymphoma
This trial will test whether injections of a patient's own anti-EBV TCR-T cells are safe and help adults (18–70) with relapsed or refractory EBV-positive lymphoma who have HLA-A11:01.
-
Evaluating AZD3470 for relapsed or refractory blood cancers
This study is testing a new drug called AZD3470 to see if it can help people with hard-to-treat blood cancers feel better and respond to treatment.
Related topics
Quick answers
How many Peripheral T-cell Lymphoma (PTCL) clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 11 countries. The most sites are in China (2 trials), Australia (1 trial), Brazil (1 trial), France (1 trial), Germany (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 1, Early Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.